Arrowgrass Capital Partners (US)’s Amgen AMGN Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-10,904	Closed	-$1.93M	–	573
2017 Q2	$1.88M	Sell	10,904 -36,413	-77%	-$5.92M	0.01%	477
2017 Q1	$7.76M	Buy	47,317 +10,035	+27%	+$1.67M	0.08%	280
2016 Q4	$5.45M	Buy	37,282 +16,546	+80%	+$2.49M	0.06%	254
2016 Q3	$3.46M	Buy	20,736 +6,479	+45%	+$1.1M	0.05%	251
2016 Q2	$2.17M	Sell	14,257 -30,812	-68%	-$4.79M	0.02%	271
2016 Q1	$6.76M	Buy	+45,069	New	+$6.7M	0.08%	153
2014 Q4	–	Sell	-219,290	Closed	-$30.8M	–	424
2014 Q3	$30.8M	Buy	+219,290	New	+$28.6M	0.75%	23
2013 Q4	–	Sell	-109,347	Closed	-$12.2M	–	156
2013 Q3	$12.2M	Buy	+109,347	New	+$11.9M	0.46%	51

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s AMGN Position: Q3 2017 in Review

Arrowgrass Capital Partners (US) sold out of Amgen (AMGN) in Q3 2017, closing a stake of 10,904 shares — an estimated $1.93M sold.

Arrowgrass Capital Partners (US) first reported a position in AMGN in Q3 2013 and held it in 8 quarters. The position peaked at $30.8M in Q3 2014. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

Arrowgrass Capital Partners (US) reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
Arrowgrass Capital Partners (US) sold 10,904 Amgen shares in Q3 2017, an estimated $1.93M.
Arrowgrass Capital Partners (US) first reported a position in Amgen in Q3 2013 and held it in 8 quarters.
Arrowgrass Capital Partners (US)'s Amgen position peaked at $30.8M in Q3 2014.
1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2017, filed 14 Nov 2017.